Delivery Order SPE2DB22D2009-SPE2DB24FL9BH
- Not listed
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,377.96, is for the delivery of 4,567,553,701 units of Ondansetron ODT 4 mg tablets. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical distribution company. The delivery order is for the supply of 4,564,164,377 units of the drug Ondansetron ODT 8 mg tablet, in packs of 30, with a ceiling value of $4,794.77. The order has an ultimate completion date of April 3, 2024. AmerisourceBergen Drug Corp holds an indefinite delivery contract...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The $5,373.53 award is for the supply of 4,563,943,906 units of Ondansetron ODT 8 mg tablets. AmerisourceBergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with a potential value of $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to provide pharmaceutical...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $1,168.60 order is for the supply of ondansetron ODT 4 mg tablets to support military treatment programs and facilities. The delivery order was issued under an indefinite delivery contract (IDC) with a potential value of $999,999,999.00 awarded solely...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a subsidiary of AmerisourceBergen Corporation. The order is for the supply of 4,563,982,184 units of the pharmaceutical product Ondansetron ODT 4 mg tablets, packaged in 30s. The delivery order has a ceiling value of $5,636.04 and an ultimate completion date of March 18, 2024. No set-aside designation was used. AmerisourceBergen Drug Corporation,...
- This is a $6,028.96 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The order is for the supply of 4,565,617,751 units of Ondansetron ODT 4 mg tablets to support military treatment programs and facilities. The award has an ultimate completion date of August 29, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued...
- This is a $8,769.42 firm fixed price delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The order is for the supply of 4,564,233,461 units of the pharmaceutical product Ondansetron ODT 4 mg tablets. This delivery order was awarded under an indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp, which has a potential total value of $999,999,999.00 and a performance...
- This $8,987.05 firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the Amerisourcebergen Corporation, to provide 4,564,205,713 units of Ondansetron ODT 4 mg tablets. The award is part of an indefinite delivery contract (IDC) with a potential value of $999,999,999.00 that enables Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA Troop Support Medical facilities...
- This is a $11,860.22 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets. The award has an ultimate completion date of August 16, 2024. AmerisourceBergen, a major pharmaceutical distributor, is providing these prescription medications to support military treatment facilities and other federal healthcare programs. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with...
- This is a $9,431.17 Firm Fixed Price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The delivery order is for 4,561,622,719 units of Ondansetron ODT 4 mg Tablets, with a period of performance ending on July 28, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- SPE2DB22D2009Indefinite Delivery Contract
- SPE2DB22D2009-SPE2DB24FL9BHDelivery Order
This is a firm fixed price delivery order for $13,846.57 awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The order is for the supply of 4,564,205,429 units of the pharmaceutical product Ondansetron ODT 4 mg tablet in 30-count packages. The delivery order has an ultimate completion date of April 9, 2024. AmerisourceBergen Drug Corp holds an indefinite delivery contract with DLA valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to provide pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. This delivery order does not have a set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.8k | 4/8/24 |